Strengers, P.F.W.

c 1-inh attack patient 1-inh study 1-inhibitor c 1-inhibitor angioedema treatment prophylactic level inhibitor range c 1 inhibitor c 4 levels product pharmacokinetic prophylactic study cetor number prophylactic treatment parameter netherland medication c 4 level safety activity on-demand study prophylaxi angioedema attacks process efficacy hae patients manufacturing process on-demand allergy blood administration concentration c 1-inhibitor levels c 1inh c 1-inhibitor antigen aae patient therapy allergy asthma immunol immunol period event plasma allergy clin virus c 1-inhibitor antibodies c 1-inhibitor products department c 1-inhibitor deficiency table antigen nanofiltered nanofiltration c 1-inhibitor activity relief pk study study period 1-esterase hospital production process time-to-relief cetor ® manufacturing increase attenuated androgens study medication cicardi phase severity time-to-resolve population infusion amsterdam antibody